RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • One-year outcomes of Aflibercept for refractory diabetic macular edema in Bevacizumab nonresponders.

One-year outcomes of Aflibercept for refractory diabetic macular edema in Bevacizumab nonresponders.

Add to Collection
2021 Feb Others Fist_Author_Year_PM

Full Author : ['Salimi, Ali', 'Vila, Natalia', 'Modabber, Milad', 'Kapusta, Michael']
Journal Title : Indian journal of ophthalmology
Chapter : Section3
Journal Year : 2021
Cited by : Not Available

PURPOSE: A sub-population of patients with diabetic macular edema (DME) responds less effectively to off-label use of Bevacizumab. Approval of Aflibercept for DME has offered Bevacizumab nonresponders an alternative therapeutic option. Herein, we investig.....

Keywords : ["refractory diabetic macular edema", "oneyear outcome", "bevacizumab nonresponder", "aflibercept"]